reports
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Continue to Ride the Trend Higher Our outlook remains bullish and the significant end-of-year rally that we have been expecting since mid-October is in full swing; continue to ride the trend higher. Our election day Compass report (11/5/24) was titled "Buy the Pullback," and last week's Compass (11/19/24) was similarly titled "Buy the Pullback Again" considering our expectation for support at the 20-day MAs on the Russell 2000 (IWM), S&P 500, and Nasdaq 100 (QQQ) with small- and mid-caps likely...
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MAR MARRIOTT INTERNATIONAL INC. CLASS A
H HYATT HOTELS CORPORATION CLASS A
CHH CHOICE HOTELS INTERNATIONAL INC.
APEI AMERICAN PUBLIC EDUCATION
CCL CARNIVAL CORPORATION
LNC LINCOLN NATIONAL CORPORATION
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
HGV HILTON GRAND VACATIONS INC.
LAUR LAUREATE EDUCATION INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
WH WYNDHAM HOTELS & RESORTS INC.
PRDO PERDOCEO EDUCATION CORP
LRN STRIDE INC
Absci to Participate in the 36th Annual Piper Sandler Healthcare Confe...
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference VANCOUVER, Wash. and NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 36th Annual Piper Sandler Healthcare Conference in New York, NY. Absci’s Founder & CEO Sean McClain is scheduled to participate in a panel discussion titled “The Promise of AI in Drug Development” on Thursday, December 5th at 2:00 p.m. Eastern Time. Interested parties may contact their Piper Sandler r...
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conf...
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 36th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 36th Annual Healthcare Conference at 12:00 pm ET on December 3rd, 2024. Interested parties can access the live and archived webcast at . About TELA ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
HBI HANESBRANDS INC.
ESE ESCO TECHNOLOGIES INC.
DGX QUEST DIAGNOSTICS INCORPORATED
DAR DARLING INGREDIENTS INC.
FLR FLUOR CORPORATION
HWBK HAWTHORN BANCSHARES
CENX CENTURY ALUMINUM COMPANY
UEIC UNIVERSAL ELECTRONICS INC.
WEYS WEYCO GROUP INC.
PNRG PRIMEENERGY RESOURCES
TPB TURNING POINT BRANDS
SENEA SENECA FOODS CORP. CL A
AA ALCOA CORPORATION
LMB LIMBACH HOLDINGS
SRTS SENSUS HEALTHCARE
ATGE ADTALEM GLOBAL EDUCATION INC.
DESP DESPEGAR.COM CORP.
SMID SMITH MIDLAND
FGBI FIRST GUARANTY BANCSHARES
NVST ENVISTA HOLDINGS
AFRM AFFIRM HOLDINGS
SPNT SIRIUSPOINT LTD
LMND LEMONADE INC
PAY PAYMENTUS HLDGS INC
COIN COINBASE GLOBAL INC
RKLB ROCKET LAB USA INC
PPTA PERPETUA RESOURCES CORP
ROOT ROOT INC
LUNR INTUITIVE MACHINES INC
HIPO HIPPO HLDGS INC
BG BUNGE LIMITED
LB LANDBRIDGE COMPANY LLC
FOA FINANCE OF AMERICA COMPANIES INC.
HOYFY HUHTAMAKI (VAN LEER) OYJ ADR 144A
Absci Reports Business Updates and Third Quarter 2024 Financial and Op...
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration with Twist Bioscience to design a novel antibody using generative AI VANCOUVER, Wash. and NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the quarter ended September 30, 2024. "The recent progress we have made across our po...
- Jonathan Moreland
LOGI LOGITECH INTERNATIONAL S.A.
TCBI TEXAS CAPITAL BANCSHARES INC.
RRGB RED ROBIN GOURMET BURGERS INC.
PPSI PIONEER POWER SOLUTIONS
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
CROX CROCS INC.
AIN ALBANY INTERNATIONAL CORP. CLASS A
NSC NORFOLK SOUTHERN CORPORATION
ATLO AMES NATIONAL CORP.
TAYD TAYLOR DEVICES INC.
FBK FB FINANCIAL CORPORATION
CDZI CADIZ INC.
JELD JELD-WEN HOLDING INC.
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
SNBR SLEEP NUMBER CORPORATION
ESQ ESQUIRE FINANCIAL HOLDINGS
MPB MID PENN BANCORP INC.
NWPP NEW PEOPLES BANKSHARES INC.
MEC MAYVILLE ENGINEERING
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
TELA TELA BIO
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
BDSX BIODESIX
MODV MODIVCARE INC
UAN CVR PARTNERS LP
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
TRIN TRINITY CAPITAL INC
BGS B&G FOODS
NRDS INC.
MAIA NERDWALLET INC
SKYH MAIA BIOTECHNOLOGY INC
MBLY SKY HARBOUR GROUP CORP
NE MOBILEYE GLOBAL INC
CALC NOBLE CORP (NEW)
BYON CALCIMEDICA INC.
DRUG BEYON 3D LTD
IKT BRIGHT MINDS BIOSCIENCES INC
ARR INHIBIKASE THERAPEUTICS INC.
MIO ARMOUR RESIDENTIAL REIT INC.
OI PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
WPC OWENS ILLINOIS INC.
UMAC W. P. CAREY AND CO. LLC
EVM UNUSUAL MACHS INC NEV
PDYN EATON VANCE INSD CALIF MUN BD FD
SARCOS TECHNOLOGY AND ROBOTICS CORP
TELA Bio Reports Third Quarter 2024 Financial Results
TELA Bio Reports Third Quarter 2024 Financial Results Reiterates 2024 Revenue Guidance and Expects Recently Implemented Operational Efficiency Improvements to Reduce Operating Expenses in 2025 MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Reported revenue of $19.0 million in the third quarter, representing growth of 26% over the prior year pe...
Absci to Host R&D Day on December 12, 2024
Absci to Host R&D Day on December 12, 2024 VANCOUVER, Wash. and NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will host its 2024 R&D Day on Thursday, December 12th in New York City. The program will begin at 9:00 a.m. Eastern Time and feature presentations from members of Absci’s leadership team as well as guest speakers, followed by an interactive Q&A session. The program is expected to conclude at approximately 12:00 p.m. Eastern Time. Interested parties may access a live and ...
Sono-Tek Announces Share Buyback
Sono-Tek Announces Share Buyback MILTON, N.Y., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that its Board of Directors has authorized the repurchase of up to $2.0 million of Sono-Tek’s outstanding common stock (the “Repurchase Program”). Dr. Christopher L Coccio, Executive Chairman, stated, “We are pleased to announce the Repurchase Program and believe that it demonstrates our financial strength and confidence in our long-term growth strategy. With our solid balance sheet an...
- Jonathan Moreland
LOGI LOGITECH INTERNATIONAL S.A.
TCBI TEXAS CAPITAL BANCSHARES INC.
RRGB RED ROBIN GOURMET BURGERS INC.
PPSI PIONEER POWER SOLUTIONS
MITK MITEK SYSTEMS INC.
GDOT GREEN DOT CORPORATION CLASS A
CROX CROCS INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
ANGO ANGIODYNAMICS INC.
DKL DELEK LOGISTICS PARTNERS
NSC NORFOLK SOUTHERN CORPORATION
EBF ENNIS
ATLO AMES NATIONAL CORP.
TAYD TAYLOR DEVICES INC.
RELL RICHARDSON ELECTRONICS LTD.
FBK FB FINANCIAL CORPORATION
AVK ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
GATX GATX CORP
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
RFIL RF INDUSTRIES LTD.
ZIVO ZIVO BIOSCIENCE
ANIX INC.
NFE ANIXA BIOSCIENCES
GRX NEW FORTRESS ENERGY
TELA THE GABELLI HEALTHCARE & WELLNESSRX TRUST
DYNR TELA BIO
CSU DYNARESOURCE INC.
MODV CAPITAL SENIOR LIVING
NUVB MODIVCARE INC
SMMT NUVATION BIO INC (A)
BMEA SUMMIT THERAPEUTICS INC
NRDS BIOMEA FUSION
TBBK INC.
BIGZ NERDWALLET INC
SKYH THE BANCORP
CALC INC.
BYON BLACKROCK INNOVATION AND GROWTH TST
SRFM SKY HARBOUR GROUP CORP
IKT CALCIMEDICA INC.
ENGN BEYON 3D LTD
APRE SURF AIR MOBILITY INC.
IDR INHIBIKASE THERAPEUTICS INC.
OCX ENGENE HOLDINGS INC
MIO APREA THERAPEUTICS INC
CLNN IDAHO STRATEGIC RESOURCES INC
SIRI ONCOCYTE CORPORATION
UMAC PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
VERB CLENE INC
SIRIUS XM HLDGS INC NEW
UNUSUAL MACHS INC NEV
VERB TECHNOLOGY COMPANY INC.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 5,400 shares of its common stock to six newly-hired employees, with a grant date of November 1, 2024 (the "Grant Date"). The restricted stock units were granted purs...
Absci and Twist Bioscience Collaborate to Design Novel Antibody using ...
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI Collaboration brings together Absci’s Generative AI drug creation platform with Twist’s DNA synthesis platform to accelerate the design of a novel therapeutic antibody VANCOUVER, Wash. and SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABSI) a data-first generative AI drug creation company, and (NASDAQ: TWST) a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today unveiled a collaboration to design a novel the...
Sono-Tek Announces Participation at The Spartan Capital Investor Confe...
Sono-Tek Announces Participation at The Spartan Capital Investor Conference Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement MILTON, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4th at the Pierre Hotel in New York. Steve Harshbarger, CEO & President of Sono-Tek will provide a formal presentation to investor attendees at 2:20 PM ET. To schedule a one-on-one me...
- Jonathan Moreland
MAN MANPOWERGROUP
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
RRGB RED ROBIN GOURMET BURGERS INC.
PPSI PIONEER POWER SOLUTIONS
MOFG MIDWESTONE FINANCIAL GROUP
MITK MITEK SYSTEMS INC.
KVHI KVH INDUSTRIES INC.
GDOT GREEN DOT CORPORATION CLASS A
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
ANGO ANGIODYNAMICS INC.
AHH ARMADA HOFFLER PROPERTIES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
DKL DELEK LOGISTICS PARTNERS
NSC NORFOLK SOUTHERN CORPORATION
EBF ENNIS
RELL RICHARDSON ELECTRONICS LTD.
FBK FB FINANCIAL CORPORATION
AVK ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
GATX GATX CORP
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
RFIL RF INDUSTRIES LTD.
ZIVO ZIVO BIOSCIENCE
ANIX INC.
INMB ANIXA BIOSCIENCES
NFE INMUNE BIO
TELA INC.
DYNR NEW FORTRESS ENERGY
CSU TELA BIO
VRDN DYNARESOURCE INC.
MODV CAPITAL SENIOR LIVING
NUVB VIRIDIAN THERAPEUTICS INC
CTLP MODIVCARE INC
SMMT NUVATION BIO INC (A)
BMEA CANTALOUPE
NRDS INC.
BHVN SUMMIT THERAPEUTICS INC
BIGZ BIOMEA FUSION
BUKS INC.
SRFM NERDWALLET INC
IKT BIOHAVEN LTD
ENGN BLACKROCK INNOVATION AND GROWTH TST
APRE BUTLER NATIONAL CORP
ASGI SURF AIR MOBILITY INC.
IDR INHIBIKASE THERAPEUTICS INC.
OCX ENGENE HOLDINGS INC
BNTC APREA THERAPEUTICS INC
CLNN ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
SIRI IDAHO STRATEGIC RESOURCES INC
ONCOCYTE CORPORATION
BENITEC BIOPHARMA INC
CLENE INC
SIRIUS XM HLDGS INC NEW
- Jonathan Moreland
Absci to Participate in Upcoming Investor Conferences
Absci to Participate in Upcoming Investor Conferences VANCOUVER, Wash. and NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. Truist Securities BioPharma Symposium (New York, NY)Hosting 1x1 meetings on Thursday, November 7 Guggenheim Securities Inaugural Healthcare Innovation Conference (Boston, MA)Fireside chat on Monday, November 11 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings UB...
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-...
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants MALVERN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the pricing of an underwritten public offering of 12,000,000 shares of its common stock at a price to the public of $2.25 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 5,800,000 shares of common stock at a public offering price of $2.2499 per pre-funded warrant...
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Fu...
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of its common stock. In addition, TELA expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the secu...
TELA Bio to Announce Third Quarter 2024 Financial Results
TELA Bio to Announce Third Quarter 2024 Financial Results MALVERN, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2024 financial results on Thursday, November 7, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Third Quarter Earnings Conference Call and Webcast DetailsInves...
Absci to Report Business Updates and Third Quarter 2024 Financial and ...
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024 VANCOUVER, Wash. and NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the third quarter before market open on Tuesday, November 12, 2024. Absci management will webcast a corresponding conference call beginning at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time to discuss its business developments, financial ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.